Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
|
|
AiXin Life International, Inc. (AIXN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 07/25/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 06/02/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/16/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/17/2023 |
8-K
| Quarterly results |
| 04/05/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 02/13/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/13/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 01/27/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 01/24/2023 |
3
| Lee Hsin-Liang Christopher (Director) has filed a Form 3 on AiXin Life International, Inc. |
| 01/17/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 01/12/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 01/09/2023 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 12/29/2022 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 12/19/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 12/01/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/04/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 10/27/2022 |
8-K/A
| Quarterly results |
| 10/06/2022 |
8-K/A
| Quarterly results |
| 10/03/2022 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM",
"REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM",
"YUNNAN RUNCANGSHENG TECHNOLOGY COMPANY LIMITED NOTES TO FINANCIAL STATEMENTS 1. ORGANIZATION AND DESCRIPTION OF BUSINESS Yunnan Runcangsheng Technology Company Limited , was incorporated on April 17, 2020 in Kunming City, Yunnan Province in China. The Company is engaged in biotechnology research and consultation, and the manufacturing and sales of health supplement products. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles . The functional currency of the Company is Chinese Renminbi . The accompanying financial statements are translated from RMB and presented in U.S. dollars . Covid - 19 On March 11, 2020, the World Health Organization announced that infect...",
"AIXIN LIFE INTERNATIONAL, INC. UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2022 AIXIN LIFE INTERNATIONAL, INC. YUNNAN RUNCANGSHENG TECHNOLOGY COMPANY LIMITED PRO FORMA ADJUSTMENTS PRO FORMA CONSOLIDATED ASSETS Current Assets Cash and cash equivalents $ 8,129,696 $ 706,753 $ - $ 8,836,449 Restricted cash 61,588 - 61,588 Accounts receivable, net 60,548 239,681 {d} 248,517 Accounts receivable, related party - 220,746 220,746 Other receivables and prepaid expense 46,702 15,024 61,726 Advance to suppliers 143,421 112,684 256,105 Advance to related parties 82,374 - 82,374 Inventory 291,918 394,745 686,663 Total Current Assets 8,816,247 1,689,633 # 10,454,168 Non-Current Assets Investment - - 6,194,762 {b} - {c} Goodwill 5,705,562 {c} 5,705,562 Property and equipment, net 221,9..." |
|
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/25/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/15/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 11/22/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/16/2021 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 10/14/2021 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM",
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM",
"CHENGDU AIXIN SHANGYAN HOTEL MANAGEMENT CO., LTD. BALANCE SHEETS June 30, December 31, 2021 2020 ASSETS CURRENT ASSETS Cash and cash equivalents 19,039 512 Accounts receivable, net 27,163 16,189 Accounts receivable, related party 6,020 60,262 Other receivables 40,050 45,160 Prepaid expenses 65,229 102,715 Inventory, net 184,739 52,642 Prepaid taxes - 7,090 Total current assets 342,240 284,570 NON-CURRENT ASSETS Property and equipment, net 309,883 321,587 Intangible assets, net 3,213 4,465 Security deposits 92,928 91,954 Operating lease right-of-use assets 1,684,168 2,007,370 Total non-current assets 2,090,192 2,425,376 TOTAL ASSETS $ 2,432,432 $ 2,709,946 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable 284,498 25,378 Deferred revenue 293,857 283,974 Accrued liabi...",
"CHENGDU AIXINTANG PHARMACY CO., LTD AND AFFILIATES COMBINED BALANCE SHEETS June 30, December 31, 2021 2020 ASSETS CURRENT ASSETS Cash and cash equivalents $ 80,148 $ 80,319 Accounts receivable, net 23,968 20,849 Advance to suppliers 5,238 2,318 Other receivables and prepaid expense 90,722 76,408 Inventory, net 113,541 109,808 Total current assets 313,617 289,702 NON-CURRENT ASSETS Property and equipment, net 5,224 7,930 Operating lease right-of-use assets 436,923 270,432 Total non-current assets 442,147 278,362 TOTAL ASSETS $ 755,764 $ 568,064 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable $ 79,013 $ 68,587 Accrued liabilities and other payables 53,491 54,270 Due to related parties 1,452,597 1,161,699 Taxes payable - 246 Operating lease liabilities - current 154...",
"AIXIN LIFE INTERNATIONAL, INC. UNAUDITED PRO FORMA COMBINED BALANCE SHEET AS OF JUNE 30, 2021 AIXIN LIFE INTERNATIONAL, INC. AIXINTANG PHARMACIES AIXIN SHANGYAN HOTEL PRO FORMA ADJUSTMENTS PRO FORMA COMBINED ASSETS Current Assets Cash and cash equivalents $ 3,248,619 $ 80,148 $ 19,039 $ {b} $ 681,165 Accounts receivable, net - 23,968 27,163 51,131 Accounts receivable, related party - - 6,020 6,020 Other receivables and prepaid expense 33,525 90,722 105,279 229,526 Advance to suppliers 271,130 5,238 - 276,368 Prepayment for acquisition 4,504,418 - - {b} - Advance to related parties 199,843 - - 199,843 Inventory 135,066 113,541 184,739 433,346 Total Current Assets 8,392,601 313,617 342,240 1,877,399 Non-Current Assets Property and equipment, net 57,643 5,224 309,883 372,750 Intangible assets..." |
|
| 08/23/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/17/2021 |
8-K/A
| Quarterly results |
| 08/17/2021 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/16/2021 |
8-K/A
| Financial Statements and Exhibits |
|
|
|